| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |